Drugs / RBCPF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01701531 | Oct 2012 → May 2014 | anemia | Targeted Medical Pharma | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RBCPF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01701531 ↗ |
| Modality | Other / unclassified | “an amino acid based, RBC precursor formulation” NCT01701531 ↗ |